Association between misty mesentery with baseline or new diagnosis of cancer: a matched cohort study
We compared the prevalence of a baseline diagnosis of cancer in patients with and without misty mesentery (MM) and determined its association with the development of a new cancer. This was a retrospective, HIPAA-compliant, IRB-approved case-control study of 148 cases and 4:1 age- and gender-matched...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Marcus, Sivan G. [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2018transfer abstract |
|---|
| Umfang: |
5 |
|---|
| Übergeordnetes Werk: |
Enthalten in: A study of Parylene coated Pd/Mg nanoblabes for reversible hydrogen storage - 2013transfer abstract, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:50 ; year:2018 ; pages:57-61 ; extent:5 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.clinimag.2017.12.006 |
|---|
| Katalog-ID: |
ELV043555969 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV043555969 | ||
| 003 | DE-627 | ||
| 005 | 20230626003822.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180726s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.clinimag.2017.12.006 |2 doi | |
| 028 | 5 | 2 | |a GBV00000000000287A.pica |
| 035 | |a (DE-627)ELV043555969 | ||
| 035 | |a (ELSEVIER)S0899-7071(17)30254-1 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 660 |q VZ |
| 082 | 0 | 4 | |a 620 |q VZ |
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 44.94 |2 bkl | ||
| 100 | 1 | |a Marcus, Sivan G. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Association between misty mesentery with baseline or new diagnosis of cancer: a matched cohort study |
| 264 | 1 | |c 2018transfer abstract | |
| 300 | |a 5 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a We compared the prevalence of a baseline diagnosis of cancer in patients with and without misty mesentery (MM) and determined its association with the development of a new cancer. This was a retrospective, HIPAA-compliant, IRB-approved case-control study of 148 cases and 4:1 age- and gender-matched controls. Statistical tests included chi-square, t-test, hazard models, and C-statistic. Patients with MM were less likely to have cancer at baseline (RR=0.74, p =0.003), but more likely to develop a new malignancy on follow-up (RR=2.13, p =0.003; survival analysis HR 1.74, p =0.05). MM may confer an increased probability of later developing cancer, particularly genitourinary tumors. | ||
| 520 | |a We compared the prevalence of a baseline diagnosis of cancer in patients with and without misty mesentery (MM) and determined its association with the development of a new cancer. This was a retrospective, HIPAA-compliant, IRB-approved case-control study of 148 cases and 4:1 age- and gender-matched controls. Statistical tests included chi-square, t-test, hazard models, and C-statistic. Patients with MM were less likely to have cancer at baseline (RR=0.74, p =0.003), but more likely to develop a new malignancy on follow-up (RR=2.13, p =0.003; survival analysis HR 1.74, p =0.05). MM may confer an increased probability of later developing cancer, particularly genitourinary tumors. | ||
| 700 | 1 | |a Candia, Susana |4 oth | |
| 700 | 1 | |a Kohli, Marc D. |4 oth | |
| 700 | 1 | |a Mongan, John |4 oth | |
| 700 | 1 | |a Zagoria, Ronald J. |4 oth | |
| 700 | 1 | |a Behr, Spencer C. |4 oth | |
| 700 | 1 | |a Sun, Derek |4 oth | |
| 700 | 1 | |a Westphalen, Antonio C. |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier Science |t A study of Parylene coated Pd/Mg nanoblabes for reversible hydrogen storage |d 2013transfer abstract |g Amsterdam [u.a.] |w (DE-627)ELV011562358 |
| 773 | 1 | 8 | |g volume:50 |g year:2018 |g pages:57-61 |g extent:5 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.clinimag.2017.12.006 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a GBV_ILN_20 | ||
| 912 | |a GBV_ILN_22 | ||
| 912 | |a GBV_ILN_30 | ||
| 912 | |a GBV_ILN_40 | ||
| 912 | |a GBV_ILN_70 | ||
| 936 | b | k | |a 44.94 |j Hals-Nasen-Ohrenheilkunde |q VZ |
| 951 | |a AR | ||
| 952 | |d 50 |j 2018 |h 57-61 |g 5 | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
s g m sg sgm |
|---|---|
| matchkey_str |
marcussivangcandiasusanakohlimarcdmongan:2018----:soitobtenitmsneyihaeieredanssfa |
| hierarchy_sort_str |
2018transfer abstract |
| bklnumber |
44.94 |
| publishDate |
2018 |
| allfields |
10.1016/j.clinimag.2017.12.006 doi GBV00000000000287A.pica (DE-627)ELV043555969 (ELSEVIER)S0899-7071(17)30254-1 DE-627 ger DE-627 rakwb eng 610 610 DE-600 660 VZ 620 VZ 610 VZ 44.94 bkl Marcus, Sivan G. verfasserin aut Association between misty mesentery with baseline or new diagnosis of cancer: a matched cohort study 2018transfer abstract 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier We compared the prevalence of a baseline diagnosis of cancer in patients with and without misty mesentery (MM) and determined its association with the development of a new cancer. This was a retrospective, HIPAA-compliant, IRB-approved case-control study of 148 cases and 4:1 age- and gender-matched controls. Statistical tests included chi-square, t-test, hazard models, and C-statistic. Patients with MM were less likely to have cancer at baseline (RR=0.74, p =0.003), but more likely to develop a new malignancy on follow-up (RR=2.13, p =0.003; survival analysis HR 1.74, p =0.05). MM may confer an increased probability of later developing cancer, particularly genitourinary tumors. We compared the prevalence of a baseline diagnosis of cancer in patients with and without misty mesentery (MM) and determined its association with the development of a new cancer. This was a retrospective, HIPAA-compliant, IRB-approved case-control study of 148 cases and 4:1 age- and gender-matched controls. Statistical tests included chi-square, t-test, hazard models, and C-statistic. Patients with MM were less likely to have cancer at baseline (RR=0.74, p =0.003), but more likely to develop a new malignancy on follow-up (RR=2.13, p =0.003; survival analysis HR 1.74, p =0.05). MM may confer an increased probability of later developing cancer, particularly genitourinary tumors. Candia, Susana oth Kohli, Marc D. oth Mongan, John oth Zagoria, Ronald J. oth Behr, Spencer C. oth Sun, Derek oth Westphalen, Antonio C. oth Enthalten in Elsevier Science A study of Parylene coated Pd/Mg nanoblabes for reversible hydrogen storage 2013transfer abstract Amsterdam [u.a.] (DE-627)ELV011562358 volume:50 year:2018 pages:57-61 extent:5 https://doi.org/10.1016/j.clinimag.2017.12.006 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_30 GBV_ILN_40 GBV_ILN_70 44.94 Hals-Nasen-Ohrenheilkunde VZ AR 50 2018 57-61 5 045F 610 |
| spelling |
10.1016/j.clinimag.2017.12.006 doi GBV00000000000287A.pica (DE-627)ELV043555969 (ELSEVIER)S0899-7071(17)30254-1 DE-627 ger DE-627 rakwb eng 610 610 DE-600 660 VZ 620 VZ 610 VZ 44.94 bkl Marcus, Sivan G. verfasserin aut Association between misty mesentery with baseline or new diagnosis of cancer: a matched cohort study 2018transfer abstract 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier We compared the prevalence of a baseline diagnosis of cancer in patients with and without misty mesentery (MM) and determined its association with the development of a new cancer. This was a retrospective, HIPAA-compliant, IRB-approved case-control study of 148 cases and 4:1 age- and gender-matched controls. Statistical tests included chi-square, t-test, hazard models, and C-statistic. Patients with MM were less likely to have cancer at baseline (RR=0.74, p =0.003), but more likely to develop a new malignancy on follow-up (RR=2.13, p =0.003; survival analysis HR 1.74, p =0.05). MM may confer an increased probability of later developing cancer, particularly genitourinary tumors. We compared the prevalence of a baseline diagnosis of cancer in patients with and without misty mesentery (MM) and determined its association with the development of a new cancer. This was a retrospective, HIPAA-compliant, IRB-approved case-control study of 148 cases and 4:1 age- and gender-matched controls. Statistical tests included chi-square, t-test, hazard models, and C-statistic. Patients with MM were less likely to have cancer at baseline (RR=0.74, p =0.003), but more likely to develop a new malignancy on follow-up (RR=2.13, p =0.003; survival analysis HR 1.74, p =0.05). MM may confer an increased probability of later developing cancer, particularly genitourinary tumors. Candia, Susana oth Kohli, Marc D. oth Mongan, John oth Zagoria, Ronald J. oth Behr, Spencer C. oth Sun, Derek oth Westphalen, Antonio C. oth Enthalten in Elsevier Science A study of Parylene coated Pd/Mg nanoblabes for reversible hydrogen storage 2013transfer abstract Amsterdam [u.a.] (DE-627)ELV011562358 volume:50 year:2018 pages:57-61 extent:5 https://doi.org/10.1016/j.clinimag.2017.12.006 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_30 GBV_ILN_40 GBV_ILN_70 44.94 Hals-Nasen-Ohrenheilkunde VZ AR 50 2018 57-61 5 045F 610 |
| allfields_unstemmed |
10.1016/j.clinimag.2017.12.006 doi GBV00000000000287A.pica (DE-627)ELV043555969 (ELSEVIER)S0899-7071(17)30254-1 DE-627 ger DE-627 rakwb eng 610 610 DE-600 660 VZ 620 VZ 610 VZ 44.94 bkl Marcus, Sivan G. verfasserin aut Association between misty mesentery with baseline or new diagnosis of cancer: a matched cohort study 2018transfer abstract 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier We compared the prevalence of a baseline diagnosis of cancer in patients with and without misty mesentery (MM) and determined its association with the development of a new cancer. This was a retrospective, HIPAA-compliant, IRB-approved case-control study of 148 cases and 4:1 age- and gender-matched controls. Statistical tests included chi-square, t-test, hazard models, and C-statistic. Patients with MM were less likely to have cancer at baseline (RR=0.74, p =0.003), but more likely to develop a new malignancy on follow-up (RR=2.13, p =0.003; survival analysis HR 1.74, p =0.05). MM may confer an increased probability of later developing cancer, particularly genitourinary tumors. We compared the prevalence of a baseline diagnosis of cancer in patients with and without misty mesentery (MM) and determined its association with the development of a new cancer. This was a retrospective, HIPAA-compliant, IRB-approved case-control study of 148 cases and 4:1 age- and gender-matched controls. Statistical tests included chi-square, t-test, hazard models, and C-statistic. Patients with MM were less likely to have cancer at baseline (RR=0.74, p =0.003), but more likely to develop a new malignancy on follow-up (RR=2.13, p =0.003; survival analysis HR 1.74, p =0.05). MM may confer an increased probability of later developing cancer, particularly genitourinary tumors. Candia, Susana oth Kohli, Marc D. oth Mongan, John oth Zagoria, Ronald J. oth Behr, Spencer C. oth Sun, Derek oth Westphalen, Antonio C. oth Enthalten in Elsevier Science A study of Parylene coated Pd/Mg nanoblabes for reversible hydrogen storage 2013transfer abstract Amsterdam [u.a.] (DE-627)ELV011562358 volume:50 year:2018 pages:57-61 extent:5 https://doi.org/10.1016/j.clinimag.2017.12.006 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_30 GBV_ILN_40 GBV_ILN_70 44.94 Hals-Nasen-Ohrenheilkunde VZ AR 50 2018 57-61 5 045F 610 |
| allfieldsGer |
10.1016/j.clinimag.2017.12.006 doi GBV00000000000287A.pica (DE-627)ELV043555969 (ELSEVIER)S0899-7071(17)30254-1 DE-627 ger DE-627 rakwb eng 610 610 DE-600 660 VZ 620 VZ 610 VZ 44.94 bkl Marcus, Sivan G. verfasserin aut Association between misty mesentery with baseline or new diagnosis of cancer: a matched cohort study 2018transfer abstract 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier We compared the prevalence of a baseline diagnosis of cancer in patients with and without misty mesentery (MM) and determined its association with the development of a new cancer. This was a retrospective, HIPAA-compliant, IRB-approved case-control study of 148 cases and 4:1 age- and gender-matched controls. Statistical tests included chi-square, t-test, hazard models, and C-statistic. Patients with MM were less likely to have cancer at baseline (RR=0.74, p =0.003), but more likely to develop a new malignancy on follow-up (RR=2.13, p =0.003; survival analysis HR 1.74, p =0.05). MM may confer an increased probability of later developing cancer, particularly genitourinary tumors. We compared the prevalence of a baseline diagnosis of cancer in patients with and without misty mesentery (MM) and determined its association with the development of a new cancer. This was a retrospective, HIPAA-compliant, IRB-approved case-control study of 148 cases and 4:1 age- and gender-matched controls. Statistical tests included chi-square, t-test, hazard models, and C-statistic. Patients with MM were less likely to have cancer at baseline (RR=0.74, p =0.003), but more likely to develop a new malignancy on follow-up (RR=2.13, p =0.003; survival analysis HR 1.74, p =0.05). MM may confer an increased probability of later developing cancer, particularly genitourinary tumors. Candia, Susana oth Kohli, Marc D. oth Mongan, John oth Zagoria, Ronald J. oth Behr, Spencer C. oth Sun, Derek oth Westphalen, Antonio C. oth Enthalten in Elsevier Science A study of Parylene coated Pd/Mg nanoblabes for reversible hydrogen storage 2013transfer abstract Amsterdam [u.a.] (DE-627)ELV011562358 volume:50 year:2018 pages:57-61 extent:5 https://doi.org/10.1016/j.clinimag.2017.12.006 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_30 GBV_ILN_40 GBV_ILN_70 44.94 Hals-Nasen-Ohrenheilkunde VZ AR 50 2018 57-61 5 045F 610 |
| allfieldsSound |
10.1016/j.clinimag.2017.12.006 doi GBV00000000000287A.pica (DE-627)ELV043555969 (ELSEVIER)S0899-7071(17)30254-1 DE-627 ger DE-627 rakwb eng 610 610 DE-600 660 VZ 620 VZ 610 VZ 44.94 bkl Marcus, Sivan G. verfasserin aut Association between misty mesentery with baseline or new diagnosis of cancer: a matched cohort study 2018transfer abstract 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier We compared the prevalence of a baseline diagnosis of cancer in patients with and without misty mesentery (MM) and determined its association with the development of a new cancer. This was a retrospective, HIPAA-compliant, IRB-approved case-control study of 148 cases and 4:1 age- and gender-matched controls. Statistical tests included chi-square, t-test, hazard models, and C-statistic. Patients with MM were less likely to have cancer at baseline (RR=0.74, p =0.003), but more likely to develop a new malignancy on follow-up (RR=2.13, p =0.003; survival analysis HR 1.74, p =0.05). MM may confer an increased probability of later developing cancer, particularly genitourinary tumors. We compared the prevalence of a baseline diagnosis of cancer in patients with and without misty mesentery (MM) and determined its association with the development of a new cancer. This was a retrospective, HIPAA-compliant, IRB-approved case-control study of 148 cases and 4:1 age- and gender-matched controls. Statistical tests included chi-square, t-test, hazard models, and C-statistic. Patients with MM were less likely to have cancer at baseline (RR=0.74, p =0.003), but more likely to develop a new malignancy on follow-up (RR=2.13, p =0.003; survival analysis HR 1.74, p =0.05). MM may confer an increased probability of later developing cancer, particularly genitourinary tumors. Candia, Susana oth Kohli, Marc D. oth Mongan, John oth Zagoria, Ronald J. oth Behr, Spencer C. oth Sun, Derek oth Westphalen, Antonio C. oth Enthalten in Elsevier Science A study of Parylene coated Pd/Mg nanoblabes for reversible hydrogen storage 2013transfer abstract Amsterdam [u.a.] (DE-627)ELV011562358 volume:50 year:2018 pages:57-61 extent:5 https://doi.org/10.1016/j.clinimag.2017.12.006 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_30 GBV_ILN_40 GBV_ILN_70 44.94 Hals-Nasen-Ohrenheilkunde VZ AR 50 2018 57-61 5 045F 610 |
| language |
English |
| source |
Enthalten in A study of Parylene coated Pd/Mg nanoblabes for reversible hydrogen storage Amsterdam [u.a.] volume:50 year:2018 pages:57-61 extent:5 |
| sourceStr |
Enthalten in A study of Parylene coated Pd/Mg nanoblabes for reversible hydrogen storage Amsterdam [u.a.] volume:50 year:2018 pages:57-61 extent:5 |
| format_phy_str_mv |
Article |
| bklname |
Hals-Nasen-Ohrenheilkunde |
| institution |
findex.gbv.de |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
A study of Parylene coated Pd/Mg nanoblabes for reversible hydrogen storage |
| authorswithroles_txt_mv |
Marcus, Sivan G. @@aut@@ Candia, Susana @@oth@@ Kohli, Marc D. @@oth@@ Mongan, John @@oth@@ Zagoria, Ronald J. @@oth@@ Behr, Spencer C. @@oth@@ Sun, Derek @@oth@@ Westphalen, Antonio C. @@oth@@ |
| publishDateDaySort_date |
2018-01-01T00:00:00Z |
| hierarchy_top_id |
ELV011562358 |
| dewey-sort |
3610 |
| id |
ELV043555969 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV043555969</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230626003822.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180726s2018 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.clinimag.2017.12.006</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000287A.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV043555969</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0899-7071(17)30254-1</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">660</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">620</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.94</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Marcus, Sivan G.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Association between misty mesentery with baseline or new diagnosis of cancer: a matched cohort study</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2018transfer abstract</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">5</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">We compared the prevalence of a baseline diagnosis of cancer in patients with and without misty mesentery (MM) and determined its association with the development of a new cancer. This was a retrospective, HIPAA-compliant, IRB-approved case-control study of 148 cases and 4:1 age- and gender-matched controls. Statistical tests included chi-square, t-test, hazard models, and C-statistic. Patients with MM were less likely to have cancer at baseline (RR=0.74, p =0.003), but more likely to develop a new malignancy on follow-up (RR=2.13, p =0.003; survival analysis HR 1.74, p =0.05). MM may confer an increased probability of later developing cancer, particularly genitourinary tumors.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">We compared the prevalence of a baseline diagnosis of cancer in patients with and without misty mesentery (MM) and determined its association with the development of a new cancer. This was a retrospective, HIPAA-compliant, IRB-approved case-control study of 148 cases and 4:1 age- and gender-matched controls. Statistical tests included chi-square, t-test, hazard models, and C-statistic. Patients with MM were less likely to have cancer at baseline (RR=0.74, p =0.003), but more likely to develop a new malignancy on follow-up (RR=2.13, p =0.003; survival analysis HR 1.74, p =0.05). MM may confer an increased probability of later developing cancer, particularly genitourinary tumors.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Candia, Susana</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kohli, Marc D.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mongan, John</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zagoria, Ronald J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Behr, Spencer C.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sun, Derek</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Westphalen, Antonio C.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="t">A study of Parylene coated Pd/Mg nanoblabes for reversible hydrogen storage</subfield><subfield code="d">2013transfer abstract</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV011562358</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:50</subfield><subfield code="g">year:2018</subfield><subfield code="g">pages:57-61</subfield><subfield code="g">extent:5</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.clinimag.2017.12.006</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_30</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.94</subfield><subfield code="j">Hals-Nasen-Ohrenheilkunde</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">50</subfield><subfield code="j">2018</subfield><subfield code="h">57-61</subfield><subfield code="g">5</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Marcus, Sivan G. |
| spellingShingle |
Marcus, Sivan G. ddc 610 ddc 660 ddc 620 bkl 44.94 Association between misty mesentery with baseline or new diagnosis of cancer: a matched cohort study |
| authorStr |
Marcus, Sivan G. |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV011562358 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health 660 - Chemical engineering 620 - Engineering & allied operations |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 660 VZ 620 VZ 610 VZ 44.94 bkl Association between misty mesentery with baseline or new diagnosis of cancer: a matched cohort study |
| topic |
ddc 610 ddc 660 ddc 620 bkl 44.94 |
| topic_unstemmed |
ddc 610 ddc 660 ddc 620 bkl 44.94 |
| topic_browse |
ddc 610 ddc 660 ddc 620 bkl 44.94 |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
s c sc m d k md mdk j m jm r j z rj rjz s c b sc scb d s ds a c w ac acw |
| hierarchy_parent_title |
A study of Parylene coated Pd/Mg nanoblabes for reversible hydrogen storage |
| hierarchy_parent_id |
ELV011562358 |
| dewey-tens |
610 - Medicine & health 660 - Chemical engineering 620 - Engineering |
| hierarchy_top_title |
A study of Parylene coated Pd/Mg nanoblabes for reversible hydrogen storage |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV011562358 |
| title |
Association between misty mesentery with baseline or new diagnosis of cancer: a matched cohort study |
| ctrlnum |
(DE-627)ELV043555969 (ELSEVIER)S0899-7071(17)30254-1 |
| title_full |
Association between misty mesentery with baseline or new diagnosis of cancer: a matched cohort study |
| author_sort |
Marcus, Sivan G. |
| journal |
A study of Parylene coated Pd/Mg nanoblabes for reversible hydrogen storage |
| journalStr |
A study of Parylene coated Pd/Mg nanoblabes for reversible hydrogen storage |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2018 |
| contenttype_str_mv |
zzz |
| container_start_page |
57 |
| author_browse |
Marcus, Sivan G. |
| container_volume |
50 |
| physical |
5 |
| class |
610 610 DE-600 660 VZ 620 VZ 610 VZ 44.94 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Marcus, Sivan G. |
| doi_str_mv |
10.1016/j.clinimag.2017.12.006 |
| dewey-full |
610 660 620 |
| title_sort |
association between misty mesentery with baseline or new diagnosis of cancer: a matched cohort study |
| title_auth |
Association between misty mesentery with baseline or new diagnosis of cancer: a matched cohort study |
| abstract |
We compared the prevalence of a baseline diagnosis of cancer in patients with and without misty mesentery (MM) and determined its association with the development of a new cancer. This was a retrospective, HIPAA-compliant, IRB-approved case-control study of 148 cases and 4:1 age- and gender-matched controls. Statistical tests included chi-square, t-test, hazard models, and C-statistic. Patients with MM were less likely to have cancer at baseline (RR=0.74, p =0.003), but more likely to develop a new malignancy on follow-up (RR=2.13, p =0.003; survival analysis HR 1.74, p =0.05). MM may confer an increased probability of later developing cancer, particularly genitourinary tumors. |
| abstractGer |
We compared the prevalence of a baseline diagnosis of cancer in patients with and without misty mesentery (MM) and determined its association with the development of a new cancer. This was a retrospective, HIPAA-compliant, IRB-approved case-control study of 148 cases and 4:1 age- and gender-matched controls. Statistical tests included chi-square, t-test, hazard models, and C-statistic. Patients with MM were less likely to have cancer at baseline (RR=0.74, p =0.003), but more likely to develop a new malignancy on follow-up (RR=2.13, p =0.003; survival analysis HR 1.74, p =0.05). MM may confer an increased probability of later developing cancer, particularly genitourinary tumors. |
| abstract_unstemmed |
We compared the prevalence of a baseline diagnosis of cancer in patients with and without misty mesentery (MM) and determined its association with the development of a new cancer. This was a retrospective, HIPAA-compliant, IRB-approved case-control study of 148 cases and 4:1 age- and gender-matched controls. Statistical tests included chi-square, t-test, hazard models, and C-statistic. Patients with MM were less likely to have cancer at baseline (RR=0.74, p =0.003), but more likely to develop a new malignancy on follow-up (RR=2.13, p =0.003; survival analysis HR 1.74, p =0.05). MM may confer an increased probability of later developing cancer, particularly genitourinary tumors. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_30 GBV_ILN_40 GBV_ILN_70 |
| title_short |
Association between misty mesentery with baseline or new diagnosis of cancer: a matched cohort study |
| url |
https://doi.org/10.1016/j.clinimag.2017.12.006 |
| remote_bool |
true |
| author2 |
Candia, Susana Kohli, Marc D. Mongan, John Zagoria, Ronald J. Behr, Spencer C. Sun, Derek Westphalen, Antonio C. |
| author2Str |
Candia, Susana Kohli, Marc D. Mongan, John Zagoria, Ronald J. Behr, Spencer C. Sun, Derek Westphalen, Antonio C. |
| ppnlink |
ELV011562358 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth |
| doi_str |
10.1016/j.clinimag.2017.12.006 |
| up_date |
2024-07-06T19:08:17.198Z |
| _version_ |
1803857844972290048 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV043555969</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230626003822.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180726s2018 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.clinimag.2017.12.006</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000287A.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV043555969</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0899-7071(17)30254-1</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">660</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">620</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.94</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Marcus, Sivan G.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Association between misty mesentery with baseline or new diagnosis of cancer: a matched cohort study</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2018transfer abstract</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">5</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">We compared the prevalence of a baseline diagnosis of cancer in patients with and without misty mesentery (MM) and determined its association with the development of a new cancer. This was a retrospective, HIPAA-compliant, IRB-approved case-control study of 148 cases and 4:1 age- and gender-matched controls. Statistical tests included chi-square, t-test, hazard models, and C-statistic. Patients with MM were less likely to have cancer at baseline (RR=0.74, p =0.003), but more likely to develop a new malignancy on follow-up (RR=2.13, p =0.003; survival analysis HR 1.74, p =0.05). MM may confer an increased probability of later developing cancer, particularly genitourinary tumors.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">We compared the prevalence of a baseline diagnosis of cancer in patients with and without misty mesentery (MM) and determined its association with the development of a new cancer. This was a retrospective, HIPAA-compliant, IRB-approved case-control study of 148 cases and 4:1 age- and gender-matched controls. Statistical tests included chi-square, t-test, hazard models, and C-statistic. Patients with MM were less likely to have cancer at baseline (RR=0.74, p =0.003), but more likely to develop a new malignancy on follow-up (RR=2.13, p =0.003; survival analysis HR 1.74, p =0.05). MM may confer an increased probability of later developing cancer, particularly genitourinary tumors.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Candia, Susana</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kohli, Marc D.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mongan, John</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zagoria, Ronald J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Behr, Spencer C.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sun, Derek</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Westphalen, Antonio C.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="t">A study of Parylene coated Pd/Mg nanoblabes for reversible hydrogen storage</subfield><subfield code="d">2013transfer abstract</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV011562358</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:50</subfield><subfield code="g">year:2018</subfield><subfield code="g">pages:57-61</subfield><subfield code="g">extent:5</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.clinimag.2017.12.006</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_30</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.94</subfield><subfield code="j">Hals-Nasen-Ohrenheilkunde</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">50</subfield><subfield code="j">2018</subfield><subfield code="h">57-61</subfield><subfield code="g">5</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.402337 |